<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Despite the vast body of epidemiological literature on the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in people with <z:mp ids='MP_0002055'>diabetes</z:mp>, few studies have examined the pattern of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk during different time windows following <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of the study was to examine the risks of site-specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in people with incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> during different time windows following <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This was a population-based retrospective cohort study </plain></SENT>
<SENT sid="3" pm="."><plain>The study period was 1 April 1994 to 31 March 2006; censoring occurred at 31 March 2006, at <z:hpo ids='HP_0011420'>death</z:hpo> or on departure from British Columbia, Canada </plain></SENT>
<SENT sid="4" pm="."><plain>Using linked health databases, we identified incident cohorts with and without <z:mp ids='MP_0002055'>diabetes</z:mp>, who were matched by age, sex and index year </plain></SENT>
<SENT sid="5" pm="."><plain>Following a minimum 2-year <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> washout period, first site-specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were identified prospectively in both cohorts </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Within 3 months following <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo>, participants with <z:mp ids='MP_0002055'>diabetes</z:mp> had significantly increased risks of colorectal, lung, liver, cervical, endometrial, ovarian, pancreatic and <z:hpo ids='HP_0012125'>prostate cancers</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>After the initial 3-month period, the risks for colorectal (HR 1.15, 95% CI 1.05, 1.25), liver (HR 2.53, 95% CI 1.93, 3.31) and endometrial (HR 1.58, 95% CI 1.28, 1.94) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> remained significantly elevated compared with those without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:mp ids='MP_0002055'>diabetes</z:mp> cohort remained at increased risk of <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> in later years, but followed a different pattern: HR 3.71 at 3 months-1 year, 2.94 at 1-2 years, 1.78 at 2-3 years and 1.65 at 3-10 years (p value for <z:hpo ids='HP_0000001'>all</z:hpo> &lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>After an initial period of elevated risk, men with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> subsequently had a decreased risk of <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> (HR 0.82, 95% CI 0.76, 0.88) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: People with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are at increased risk of select <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>; this risk is particularly elevated at the time of <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo>, which is likely to be due to increased ascertainment </plain></SENT>
</text></document>